These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Does anti-IgE therapy help in asthma? Efficacy and controversies. Avila PC Annu Rev Med; 2007; 58():185-203. PubMed ID: 17059361 [TBL] [Abstract][Full Text] [Related]
7. A drug safety review of treating eosinophilic asthma with monoclonal antibodies. Mitchell P; Leigh R Expert Opin Drug Saf; 2019 Dec; 18(12):1161-1170. PubMed ID: 31594389 [No Abstract] [Full Text] [Related]
8. Safety of omalizumab in asthma. Tan RA; Corren J Expert Opin Drug Saf; 2011 May; 10(3):463-71. PubMed ID: 21401438 [TBL] [Abstract][Full Text] [Related]
9. Omalizumab for asthma. Strunk RC; Bloomberg GR N Engl J Med; 2006 Jun; 354(25):2689-95. PubMed ID: 16790701 [No Abstract] [Full Text] [Related]
10. Characterization of asthma endotypes: implications for therapy. Stokes JR; Casale TB Ann Allergy Asthma Immunol; 2016 Aug; 117(2):121-5. PubMed ID: 27499539 [TBL] [Abstract][Full Text] [Related]
11. Real-life studies of biologics used in asthma patients: key differences and similarities to trials. Heffler E; Paoletti G; Giorgis V; Puggioni F; Racca F; Del Giacco S; Bagnasco D; Caruso C; Brussino L; Rolla G; Canonica GW Expert Rev Clin Immunol; 2019 Sep; 15(9):951-958. PubMed ID: 31389304 [No Abstract] [Full Text] [Related]
12. Biologics and biomarkers for asthma, urticaria, and nasal polyposis. Casale TB J Allergy Clin Immunol; 2017 May; 139(5):1411-1421. PubMed ID: 28477720 [TBL] [Abstract][Full Text] [Related]
13. Biologic and New Therapies in Asthma. Tabatabaian F; Ledford DK; Casale TB Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480 [TBL] [Abstract][Full Text] [Related]
14. An update on biologic-based therapy in asthma. Walsh GM Immunotherapy; 2013 Nov; 5(11):1255-64. PubMed ID: 24188679 [TBL] [Abstract][Full Text] [Related]
15. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab. Nowak D Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266 [TBL] [Abstract][Full Text] [Related]
16. An update on emerging drugs for asthma. Walsh GM Expert Opin Emerg Drugs; 2012 Mar; 17(1):37-42. PubMed ID: 22292562 [TBL] [Abstract][Full Text] [Related]
17. Omalizumab: new drug. Asthma: too many unknowns for an anti-IgE. Prescrire Int; 2007 Oct; 16(91):179-82. PubMed ID: 17926440 [TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of omalizumab in children with allergic (IgE-mediated) asthma. Milgrom H; Fowler-Taylor A; Vidaurre CF; Jayawardene S Curr Med Res Opin; 2011 Jan; 27(1):163-9. PubMed ID: 21121874 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies for the treatment of asthma. Catley MC; Coote J; Bari M; Tomlinson KL Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943 [TBL] [Abstract][Full Text] [Related]
20. [New drugs; omalizumab]. Cohen AF; Dubois EA; van Bronswijk H Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2871-2. PubMed ID: 17319219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]